Navigation Links
Chemical chaperone could open door to treatment of neurological disorder
Date:2/5/2008

An unexpected finding turned out to be a clue leading researchers at Washington University School of Medicine in St. Louis to propose a new treatment approach for Niemann-Pick disease, a rare, deadly neurodegenerative disorder.

To overcome the genetic defect in Niemann-Pick disease, the researchers suggest that chemical compounds could potentially "chaperone" mutant protein molecules through the cell's quality control machinery. And they believe the approach also could be useful for more common diseases such as cystic fibrosis that stem from a similar type of defect.

Their findings are reported in advance online publication in the Journal of Biological Chemistry.

Daniel S. Ory, M.D., associate professor of medicine, and colleagues in the Center for Cardiovascular Research originally began to study Niemann-Pick type C disease because of its link to cholesterol metabolism the genetic abnormality at the root of the disease serves as a tool for investigating how cholesterol moves about in cells.

Niemann-Pick type C, the rarest form of Niemann-Pick disease, usually affects school-aged children, but the disease may occur at any time from early infancy to adulthood. Symptoms may include unsteadiness of gait, clumsiness, slurred speech, learning difficulties, progressive intellectual decline, seizures and tremors. Niemann-Pick type C disease is fatal, and no life-extending treatment exists.

As the result of their latest research, Ory and colleagues want to follow up with an investigation of a different treatment modality than has previously been proposed. Prior avenues of treatment research emphasized using gene therapy to repair the genetic defect, but such an approach is fraught with numerous difficulties. Ory's group believes that Niemann-Pick type C and other diseases like it might be treated more readily with chemical compounds able to compensate for the effect of the disease's underlying genetic mutation. '/>"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Chemical culprit in popcorn workers lung identified
2. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
3. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
4. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
5. Low Doses of Red Wine Chemical May Fight Diabetes
6. National Academies advisory: genes and toxic chemicals
7. Genomic technologies to identify toxic chemicals should be developed
8. Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria
9. American Chemical Societys Weekly Presspac -- Oct. 17, 2007
10. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
11. Brains Reward Chemical May Help Spur Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemical chaperone could open door to treatment of neurological disorder
Chemical chaperone could open door to treatment of neurological disorder
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...f shifting around body fat to flatten your tummy a...locking that ample fat? According to an internati...ome reality. The study, published online in Natur...an cosmetic and reconstructive surgery and treatme...
...alth Scientific and Industrial Research Organisati...cy, says it has developed a blood test that has t...est, hailed as the first of its kind, essentially ...n's DNA and can point to the likelihood of certain...
...ctive study suggests that ovarian germ cell tumour... and fertility-sparing surgery may retain their m...study, published in the Journal of Clinical Oncolo...eproductive and sexual concerns, survivors were mo...
...t Victoria Beckham has imposed a strict diet regim...our that is to begin later this year. The new ri...e four members to go on a diet of edamame beans, s... and all this combined with 200 sit ups a day. "V...
Other Medicine News:Health News:Stressed Mice may Hold Clue to How Fat is Stored: Study 2Health News:A Blood Test Developed in Australia to Repair DNA Damage 2Health News:Survivors of Rare Ovarian Cancer may Retain Menstrual Function and Reproductive Ability 2Health News:Survivors of Rare Ovarian Cancer may Retain Menstrual Function and Reproductive Ability 3
(Date:9/5/2008)...tudy Demonstrates microRNAs Extracted From a Simpl...ive Clinical Biomarkers for a Wide Range of ...rietary Technology, Rosetta Genomics is Currently ...ect Colon Cancer, REHOVOT, Israel and JERSEY CITY...- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader i...
(Date:9/4/2008)...-Data Published in ,The Lancet, and Presented at E...-- Results from a new international,study, the GIS.../d dose of,omega-3 acid ethyl esters reduced all c...ascular reasons in patients with chronic heart,fai...online version of ,The,Lancet, and were presented ...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to be Pr...stCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) announce...b,an investigational anti-CTLA-4 antibody, in mel...ions at the 33rd Congress of the European Society,...2-16, 2008 in Stockholm.,Many of the following abs...
(Date:9/3/2008)...says: Wrong Question Asked. Wrong Children Studied.../PRNewswire-USNewswire/ -- A Centers for Disease,C...laims there is no link,between the MMR vaccine and...s this study does nothing to dispel the growing pu...raises several questions concerning design,and met...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3CDC Misses Target With Flawed MMR/Autism Study 2Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 14214 1Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 14214 2Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report 14214 3Medications Plus Dental Materials May Equal Infection for Diabetic Patients 14211 1Medications Plus Dental Materials May Equal Infection for Diabetic Patients 14211 2Woman and Cat Shared Super Bug 14209 1Woman and Cat Shared Super Bug 14209 2Woman and Cat Shared Super Bug 14209 3New Tools Boost Alzheimers Awareness 14206 1New Tools Boost Alzheimers Awareness 14206 2New Tools Boost Alzheimers Awareness 14206 3
...un 20, 2007 - Neoprobe Corporation,(OTCBB:NEOP), a...cardiovascular surgical and diagnostic products, t... multicenter Phase 2 clinical,study of its lead cl...DTPA-mannosyl-dextran). Lymphoseek is a proprietar...use with handheld,gamma detection devices, such as...
...rly Use of Estrogen May be,Cardio-Protective, PHOE...w analysis,of Women,s Health Initiative data publi... significant reduction in calcified,plaque for wom...ed,with women taking a placebo. This is the first ... coronary artery calcium,(CAC) has been evaluated ...
Other Medicine Technology:Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 2Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 3Arterial Plaque Significantly Reduced in Women Age 50-59 Taking,Hormones, Says New Analysis of Women's Health Initiative Data 2Arterial Plaque Significantly Reduced in Women Age 50-59 Taking,Hormones, Says New Analysis of Women's Health Initiative Data 3
Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat
Angled shaft with 1.5 mm tip designed to efficiently perform the "Stop and Chop" technique. Round knurled handle. Most popular size or model.
This double ended instrument was designed for delineating and lifting the corneal flap of previously performed lamellar refractive surgery cases.
Used when dislocating the lens. Great for chopping during phacoemulsification. Helpful in ushering the IOL out of eye. Useful to reduce possibility of iris tuck with anterior chamber IOL placement.
Medicine Products: